Mode
Text Size
Log in / Sign up

Meta-analysis shows PCI before TAVR reduces revascularization but increases bleeding risk in severe aortic stenosis patients with coronary artery diseaseRoutine PCI before TAVR doesn't save lives, increases bleeding

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Selective PCI before TAVR reduces revascularization needs but increases bleeding risk without improving survival in patients with severe aortic stenosis and coronary artery disease.

This meta-analysis evaluated 1,156 patients with severe aortic stenosis and concomitant coronary artery disease to determine the impact of PCI before TAVR. The primary outcome assessed all-cause mortality, while secondary outcomes included cardiovascular death, revascularization needs, myocardial infarction, stroke, and bleeding complications.

Results indicated that upfront PCI did not significantly reduce all-cause mortality or cardiovascular death. While the procedure significantly lowered the risk of any and urgent revascularization, it did not significantly reduce myocardial infarction rates. A borderline trend favoring PCI was observed for stroke reduction, though this did not reach statistical significance.

Safety analysis revealed a concerning increase in bleeding risks. Patients undergoing PCI before TAVR experienced a significantly higher rate of any bleeding and major bleeding compared to those with deferred PCI. Kidney injury and rehospitalization rates did not differ significantly between the two groups. These findings suggest that routine revascularization before TAVR is not universally beneficial and may expose patients to unnecessary bleeding hazards.

If you need a new heart valve and also have blocked arteries, should doctors clear those blockages first? A new analysis suggests the answer may be no.

Researchers combined data from 5 trials involving 1,156 patients with severe aortic stenosis and coronary artery disease. They compared people who got angioplasty (PCI) before valve replacement (TAVR) to those who didn't. The result: no difference in deaths from any cause or from heart problems over the follow-up period.

But there was a trade-off. People who had PCI first were less likely to need another procedure to open arteries later. However, they had nearly double the risk of any bleeding and major bleeding. Other outcomes like heart attack, stroke, kidney injury, and rehospitalization were similar between groups.

This is a meta-analysis, which combines past studies. The findings are not definitive, but they suggest that routine PCI before TAVR may not be necessary for everyone. Instead, doctors should consider each patient's individual situation before deciding on angioplasty.

What this means for you:
Routine angioplasty before valve replacement doesn't lower death risk but increases bleeding.

Study Details

Study typeMeta analysis
Sample sizen = 1,156
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Background: In severe aortic stenosis patients undergoing TAVR, whether coexisting coronary disease prompts revascularization and its optimal timing remain unclear. Aim: To evaluate the efficacy and safety of PCI before TAVR compared to deferred PCI in patients with severe aortic stenosis and concomitant coronary artery disease. Methods: We performed a meta-analysis of RCTs. PubMed, Embase, Scopus, CENTRAL, and Web of Science were searched for RCTs comparing PCI before TAVR versus no PCI. HRs with 95% CIs were pooled using random-effects models. Results: Three RCTs (ACTIVATION, NOTION 3, PRO-TAVI) enrolling 1,156 patients (579 PCI, 577 no PCI) were included. Routine PCI before TAVR did not reduce all-cause mortality (HR 0.88, 95% CI 0.67 to 1.17; p=0.38) or cardiovascular death (HR 0.77, 95% CI 0.49 to 1.19; p=0.23). PCI significantly reduced any revascularization (HR 0.24, 95% CI 0.06 to 0.86; p=0.029), and urgent revascularization (HR 0.33, 95% CI 0.12 to 0.87; p=0.025). MI was not significantly reduced with PCI (HR 0.84, 95% CI 0.44 to 1.59; p = 0.59). Stroke showed a borderline trend favoring PCI (HR 0.69, 95% CI 0.46 to 1.04; p=0.073). PCI significantly increased any bleeding (HR 1.96, 95% CI 1.28 to 3.0; p=0.002) and major bleeding (HR 1.88, 95% CI 1.07 to 3.31, p=0.027). Neither AKI nor rehospitalization differed significantly between groups. Leave-one-out sensitivity analyses confirmed the stability of mortality, stroke, and bleeding estimates. Conclusions: Routine PCI before TAVR does not reduce mortality. It lowers urgent revascularization and trends toward less stroke but nearly doubles bleeding. Findings support selective, individualized PCI rather than routine revascularization before TAVR.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.